Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.

2 articles about Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.

• Atom Bioscience Marks Gout Awareness Day by Urging Increased Patient Education on Debilitating Effects of the Chronic Disease

  5/22/2023

  Atom Bioscience, a clinical stage biotechnology company developing new treatments for metabolic and inflammatory diseases, such as gout, is calling for increased understanding of gout to help mark Gout Awareness Day, May 22, 2023.

• Atom Bioscience Announces Positive Results of Phase 2a China Clinical Trial of Its URAT1 Inhibitor for Chronic Gout

  3/1/2023

  Atom Bioscience, a clinical stage biotechnology company developing best in class treatments for inflammatory and metabolic diseases, announced positive results from its China Phase 2a clinical trial of ABP-671.